Literature DB >> 20132287

Long-term outcomes of children treated with the ketogenic diet in the past.

Amisha Patel1, Paula L Pyzik, Zahava Turner, James E Rubenstein, Eric H Kossoff.   

Abstract

PURPOSE: The ketogenic diet has well-established short- and long-term outcomes for children with intractable epilepsy, but only for those actively receiving it. However, no information exists about its long-term effects years after it has been discontinued.
METHODS: Living subjects were identified who were treated at the Johns Hopkins Hospital with the ketogenic diet from November 1993 to December 2008 for >or=1 month, and had discontinued it >or=6 months prior to this study. Of 530 patients who were eligible, 254 were successfully contacted by phone or e-mail with a survey and request for laboratory studies.
RESULTS: Questionnaires were completed by 101 patients, with a median current age of 13 years (range 2-26 years). Median time since discontinuing the ketogenic diet was 6 years (range 0.8-14 years). Few (8%) still preferred to eat high fat foods. In comparison to the 52% responder rate (>50% seizure reduction) at ketogenic diet discontinuation, 79% were now similarly improved (p = 0.0001). Ninety-six percent would recommend the ketogenic diet to others, yet only 54% would have started it before trying anticonvulsants. Lipids were normal (mean total cholesterol 158 mg/dl), despite most being abnormal while on the ketogenic diet. The mean Z scores for those younger than age 18 years were -1.28 for height and -0.79 for weight. In those 18 years of age or older, the mean body mass index (BMI) was 22.2. DISCUSSION: This is the first study to report on the long-term effects of the ketogenic diet after discontinuation. The majority of subjects are currently doing well with regard to health and seizure control.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20132287     DOI: 10.1111/j.1528-1167.2009.02488.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  29 in total

Review 1.  Low-carbohydrate ketogenic diets, glucose homeostasis, and nonalcoholic fatty liver disease.

Authors:  Rebecca C Schugar; Peter A Crawford
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2012-07       Impact factor: 4.294

Review 2.  Therapeutic role of mammalian target of rapamycin (mTOR) inhibition in preventing epileptogenesis.

Authors:  Sharon S McDaniel; Michael Wong
Journal:  Neurosci Lett       Date:  2011-02-24       Impact factor: 3.046

3.  Danger in the pipeline for the ketogenic diet?

Authors:  Eric Kossoff
Journal:  Epilepsy Curr       Date:  2014 Nov-Dec       Impact factor: 7.500

4.  Hyperlipidemia induces resistance to PTH bone anabolism in mice via oxidized lipids.

Authors:  Andrew P Sage; Jinxiu Lu; Elisa Atti; Sotirios Tetradis; Maria-Grazia Ascenzi; Douglas J Adams; Linda L Demer; Yin Tintut
Journal:  J Bone Miner Res       Date:  2011-06       Impact factor: 6.741

5.  Male mice placed on a ketogenic diet from postnatal day (P) 21 through adulthood have reduced growth, are hypoactive, show increased freezing in a conditioned fear paradigm, and have spatial learning deficits.

Authors:  Keila N Miles; Matthew R Skelton
Journal:  Brain Res       Date:  2020-01-31       Impact factor: 3.252

Review 6.  Dietary therapies for epilepsy: future research.

Authors:  Sudha K Kessler; Elizabeth G Neal; Carol S Camfield; Eric H Kossoff
Journal:  Epilepsy Behav       Date:  2011-03-26       Impact factor: 2.937

7.  The ketogenic diet inhibits the mammalian target of rapamycin (mTOR) pathway.

Authors:  Sharon S McDaniel; Nicholas R Rensing; Liu Lin Thio; Kelvin A Yamada; Michael Wong
Journal:  Epilepsia       Date:  2011-03-03       Impact factor: 5.864

Review 8.  The effects of the ketogenic diet on behavior and cognition.

Authors:  Tove Hallböök; Sunggoan Ji; Stuart Maudsley; Bronwen Martin
Journal:  Epilepsy Res       Date:  2011-08-27       Impact factor: 3.045

Review 9.  Nutritional interventions in primary mitochondrial disorders: Developing an evidence base.

Authors:  Kathryn M Camp; Danuta Krotoski; Melissa A Parisi; Katrina A Gwinn; Bruce H Cohen; Christine S Cox; Gregory M Enns; Marni J Falk; Amy C Goldstein; Rashmi Gopal-Srivastava; Gráinne S Gorman; Stephen P Hersh; Michio Hirano; Freddie Ann Hoffman; Amel Karaa; Erin L MacLeod; Robert McFarland; Charles Mohan; Andrew E Mulberg; Joanne C Odenkirchen; Sumit Parikh; Patricia J Rutherford; Shawne K Suggs-Anderson; W H Wilson Tang; Jerry Vockley; Lynne A Wolfe; Steven Yannicelli; Philip E Yeske; Paul M Coates
Journal:  Mol Genet Metab       Date:  2016-09-20       Impact factor: 4.797

10.  Ketogenic diet improves core symptoms of autism in BTBR mice.

Authors:  David N Ruskin; Julia Svedova; Jessica L Cote; Ursula Sandau; Jong M Rho; Masahito Kawamura; Detlev Boison; Susan A Masino
Journal:  PLoS One       Date:  2013-06-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.